Cargando…

A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS‐CoV‐2

Activity‐based probes are valuable tools for chemical biology. However, finding probes that specifically target the active site of an enzyme remains a challenging task. Herein, we present a ligand selection strategy that allows to rapidly tailor electrophilic probes to a target of choice and showcas...

Descripción completa

Detalles Bibliográficos
Autores principales: Peñalver, Lilian, Schmid, Philipp, Szamosvári, Dávid, Schildknecht, Stefan, Globisch, Christoph, Sawade, Kevin, Peter, Christine, Böttcher, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986205/
https://www.ncbi.nlm.nih.gov/pubmed/33350010
http://dx.doi.org/10.1002/anie.202016113
_version_ 1783668399587459072
author Peñalver, Lilian
Schmid, Philipp
Szamosvári, Dávid
Schildknecht, Stefan
Globisch, Christoph
Sawade, Kevin
Peter, Christine
Böttcher, Thomas
author_facet Peñalver, Lilian
Schmid, Philipp
Szamosvári, Dávid
Schildknecht, Stefan
Globisch, Christoph
Sawade, Kevin
Peter, Christine
Böttcher, Thomas
author_sort Peñalver, Lilian
collection PubMed
description Activity‐based probes are valuable tools for chemical biology. However, finding probes that specifically target the active site of an enzyme remains a challenging task. Herein, we present a ligand selection strategy that allows to rapidly tailor electrophilic probes to a target of choice and showcase its application for the two cysteine proteases of SARS‐CoV‐2 as proof of concept. The resulting probes were specific for the active site labeling of 3CL(pro) and PL(pro) with sufficient selectivity in a live cell model as well as in the background of a native human proteome. Exploiting the probes as tools for competitive profiling of a natural product library identified salvianolic acid derivatives as promising 3CL(pro) inhibitors. We anticipate that our ligand selection strategy will be useful to rapidly develop customized probes and discover inhibitors for a wide range of target proteins also beyond corona virus proteases.
format Online
Article
Text
id pubmed-7986205
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79862052021-03-25 A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS‐CoV‐2 Peñalver, Lilian Schmid, Philipp Szamosvári, Dávid Schildknecht, Stefan Globisch, Christoph Sawade, Kevin Peter, Christine Böttcher, Thomas Angew Chem Int Ed Engl Research Articles Activity‐based probes are valuable tools for chemical biology. However, finding probes that specifically target the active site of an enzyme remains a challenging task. Herein, we present a ligand selection strategy that allows to rapidly tailor electrophilic probes to a target of choice and showcase its application for the two cysteine proteases of SARS‐CoV‐2 as proof of concept. The resulting probes were specific for the active site labeling of 3CL(pro) and PL(pro) with sufficient selectivity in a live cell model as well as in the background of a native human proteome. Exploiting the probes as tools for competitive profiling of a natural product library identified salvianolic acid derivatives as promising 3CL(pro) inhibitors. We anticipate that our ligand selection strategy will be useful to rapidly develop customized probes and discover inhibitors for a wide range of target proteins also beyond corona virus proteases. John Wiley and Sons Inc. 2021-01-28 2021-03-15 /pmc/articles/PMC7986205/ /pubmed/33350010 http://dx.doi.org/10.1002/anie.202016113 Text en © 2020 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Peñalver, Lilian
Schmid, Philipp
Szamosvári, Dávid
Schildknecht, Stefan
Globisch, Christoph
Sawade, Kevin
Peter, Christine
Böttcher, Thomas
A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS‐CoV‐2
title A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS‐CoV‐2
title_full A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS‐CoV‐2
title_fullStr A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS‐CoV‐2
title_full_unstemmed A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS‐CoV‐2
title_short A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS‐CoV‐2
title_sort ligand selection strategy identifies chemical probes targeting the proteases of sars‐cov‐2
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986205/
https://www.ncbi.nlm.nih.gov/pubmed/33350010
http://dx.doi.org/10.1002/anie.202016113
work_keys_str_mv AT penalverlilian aligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT schmidphilipp aligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT szamosvaridavid aligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT schildknechtstefan aligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT globischchristoph aligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT sawadekevin aligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT peterchristine aligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT bottcherthomas aligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT penalverlilian ligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT schmidphilipp ligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT szamosvaridavid ligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT schildknechtstefan ligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT globischchristoph ligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT sawadekevin ligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT peterchristine ligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2
AT bottcherthomas ligandselectionstrategyidentifieschemicalprobestargetingtheproteasesofsarscov2